Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer
Article first published online: 8 JUN 2011
Copyright © 2011 Wiley Periodicals, Inc.
Volume 72, Issue 4, pages 351–360, March 2012
How to Cite
Maeda, T., Murata, M., Chiba, H., Takasawa, A., Tanaka, S., Kojima, T., Masumori, N., Tsukamoto, T. and Sawada, N. (2012), Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer. Prostate, 72: 351–360. doi: 10.1002/pros.21436
- Issue published online: 17 JAN 2012
- Article first published online: 8 JUN 2011
- Manuscript Accepted: 12 MAY 2011
- Manuscript Received: 14 DEC 2010
- Ministry of Education, Culture, Sports, Science, and Technology, Japan. Grant Numbers: 20590346, 22590336, 19390103, 19590398, 20790308
- Gohtaro Sugawara-Memorial Research Fund for Urologic Diseases
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.